Loading company…
Shanghai pharmaceutical company focused on new drug and API research, with innovative and generic drug products.
Tianci International Pharmaceutical was established in 2013 and is based in Shanghai, China. It operates as a pharmaceutical industry chain platform focused on drug research and development support, developing new drugs and APIs. Its products include the Class 1 innovative thrombolytic drug HTUPA, IDO inhibitors and amlodipine besylate tablets for hypertension and coronary heart disease. In March 2017 it closed a round of Series D funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in